You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Autoreactive T cells

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anti-Angiotensin-Receptor 1-, Anti-Endothelin-Receptor

Completed
  • Cardiac Failure
    • Wetzikon, Switzerland
      GZO Regional Health Center
    Jul 13, 2021

    Autoreactive B Cells in Membranous Nephropathy

    Recruiting
    • Membranous Nephropathy
    • In vitro assays.
    • Ranica, BG, Italy
      Centro di Ricerche Cliniche per le Malattie Rare " Aldo e Cele D
    Nov 2, 2022

    Rheumatoid Arthritis Trial in Leiden (Filgotinib, Adalimumab)

    Not yet recruiting
    • Rheumatoid Arthritis
    • Leiden, Zuid-Holland, Netherlands
      Leiden University Medical Center
    Aug 14, 2022

    Membranous Nephropathy Trial in New York (ACTHar)

    Completed
    Has Results
    • Membranous Nephropathy
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Jul 20, 2022

    CAR-T Cell Therapy Trial in Shanghai (GC012F injection)

    Recruiting
    • CAR-T Cell Therapy
    • GC012F injection
    • Shanghai, Shanghai, China
      Department of Rheumatology, Ren Ji Hospital South Campus, School
    May 5, 2023

    Multiple Myeloma Trial (BCMA-TGFß CAR-T cells (0.75 x10^6 cells/kg), BCMA-TGFß CAR-T cells (1 x 10^6 cells/kg), BCMA-TGFß CAR-T

    Not yet recruiting
    • Multiple Myeloma
    • BCMA-TGFβ CAR-T cells (0.75 x10^6 cells/kg)
    • +3 more
    • (no location specified)
    Jul 28, 2023

    Pancreatic Cancer Trial in ShangHai (TCR-T Cells Injection(GB3010 Cells Injection))

    Recruiting
    • Pancreatic Cancer
    • TCR-T Cells Injection（GB3010 Cells Injection）
    • ShangHai, Shanghai, China
      Ruijin Hospital Affiliated to Shanghai Jiaotong University Schoo
    Sep 19, 2023

    Relapse/Refractory Multiple Myeloma Trial in Hangzhou (DeepTag-GPRC5D Targeted CAR T-cells)

    Recruiting
    • Relapse/Refractory Multiple Myeloma
    • DeepTag-GPRC5D Targeted CAR T-cells
    • Hangzhou, Zhejiang, China
      The first affiliated hospital of medical college of zhejiang uni
    Oct 10, 2023

    Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage III Prostate Cancer AJCC v8 Trial in Seattle (drug,

    Not yet recruiting
    • Prostate Carcinoma
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 17, 2023

    Multiple Myeloma in Remission Trial in Shenzhen, Haikou (MM-specific universal CAR T cells)

    Recruiting
    • Multiple Myeloma in Remission
    • MM-specific universal CAR T cells
    • Shenzhen, Guangdong, China
    • +1 more
    Aug 23, 2023

    Metastatic Colorectal Adenocarcinoma, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

    Not yet recruiting
    • Metastatic Colorectal Adenocarcinoma
    • +5 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Sep 12, 2023

    Autoimmune Diseases Trial in Shenzhen, Guilin (4SCAR T cells)

    Recruiting
    • Autoimmune Diseases
    • 4SCAR T cells
    • Shenzhen, Guangdong, China
    • +1 more
    Jul 17, 2022

    Relapsed Acute Myeloid Leukaemia Trial (Cryopreserved BE CAR33 T Cells (BE752TBTTBCAR33PBL))

    Not yet recruiting
    • Relapsed Acute Myeloid Leukaemia
    • Cryopreserved BE CAR33 T Cells (BE752TBTTBCAR33PBL)
    • (no location specified)
    Jul 4, 2023

    CAR-T Trial in Hangzhou (GC012F injection)

    Recruiting
    • CAR-T
    • GC012F injection
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital,College of Medicine, Zhejiang Univ
    May 10, 2023

    TINO: T Cells in the Nose of Older Adults

    Recruiting
    • Respiratory Tract Infections
    • Aging
      • Leiden, Zuid Holland, Netherlands
        Leiden University Medical Center
      Sep 8, 2023

      T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial (CD7-CART01)

      Not yet recruiting
      • T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
      • CD7-CART01
      • (no location specified)
      Sep 26, 2023

      Glioblastoma, Malignant Glioma, Recurrent Glioblastoma Trial in Boston (CARv3-TEAM-E T cells)

      Not yet recruiting
      • Glioblastoma
      • +3 more
      • CARv3-TEAM-E T cells
      • Boston, Massachusetts
        Massachusetts General Hospital Cancer Center
      Dec 13, 2022

      Acute Myeloid Leukemia, Recurrent Adult Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Anti-CD33 CAR

      Not yet recruiting
      • Acute Myeloid Leukemia
      • +3 more
      • Anti-CD33 CAR T-cells
      • Lymphodepletion Therapy
      • Duarte, California
        City of Hope Medical Center
      Jan 3, 2023

      Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Duarte

      Not yet recruiting
      • Castration-Resistant Prostate Carcinoma
      • +2 more
      • Autologous Anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes
      • +7 more
      • Duarte, California
        City of Hope Medical Center
      Apr 5, 2023

      EBV Infection After Allogenic HSCT Trial in Beijing (EBV-TCR-T cells)

      Recruiting
      • EBV Infection After Allogenic HSCT
      • EBV-TCR-T cells
      • Beijing, Beijing, China
        Chinese PLA General Hospital
      Nov 3, 2023

      Advanced Solid Tumor Trial in Beijing (aPD1-MSLN-CAR T Cells)

      Not yet recruiting
      • Advanced Solid Tumor
      • αPD1-MSLN-CAR T Cells
      • Beijing, China
        National Cancer Center Cancer Hospital Chinese Academy of Medica
      Jul 13, 2023

      Multiple Myeloma, Immune System Diseases Trial in Chapel Hill (CAR138 T Cells)

      Recruiting
      • Multiple Myeloma
      • Immune System Diseases
      • CAR138 T Cells
      • Chapel Hill, North Carolina
        Lineberger Comprehensive Cancer Center at University of North Ca
      Jan 10, 2023

      T Lymphoblastic Leukemia/Lymphoma Trial in Shenzhen (CD7 CAR-T cells)

      Recruiting
      • T Lymphoblastic Leukemia/Lymphoma
      • CD7 CAR-T cells
      • Shenzhen, Guangdong, China
        Li Yu
      Nov 11, 2022

      Diffuse Large B-cell Lymphoma Trial in Hangzhou (Metabolically Armed CD19 CAR-T cells)

      Recruiting
      • Diffuse Large B-cell Lymphoma
      • Metabolically Armed CD19 CAR-T cells
      • Hangzhou, Zhejiang, China
        The first affiliated hospital of medical college of zhejiang uni
      Nov 1, 2023

      Metastatic Pancreatic Ductal Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Seattle (Autologous Mesothelin-specific

      Recruiting
      • Metastatic Pancreatic Ductal Adenocarcinoma
      • Stage IV Pancreatic Cancer AJCC v8
      • Autologous Mesothelin-specific TCR-T Cells
      • +2 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jan 31, 2023